September 8th, 2008
Eli Lilly and Co is likely to face a class action lawsuit for its product Zyprexa. It is a schizophrenia drug by this New York based pharmaceutical company.
Judge Jack Weinstein, of New York, certifies the class-action lawsuit against Lilly in a 295-page ruling issued today. He denied class-action status to individuals with claims against Lilly.
The lawsuit charges the drug to be responsible for weight gain and other related side effects.
Filed under Class Action, Product Liability Lawsuit | Tags: Eli Lilly and Co, schizophrenia drug, weight gain, Zyprexa | Comment Below